Patients receiving heparin therapy require monitoring of:

Questions 54

ATI RN

ATI RN Test Bank

Hematology drugs Questions

Question 1 of 5

Patients receiving heparin therapy require monitoring of:

Correct Answer: A

Rationale: In patients receiving heparin therapy, monitoring platelet levels every two to three days for thrombocytopenia that may occur on day four of therapy is crucial. Thrombocytopenia is a potential side effect of heparin therapy due to immune-mediated platelet destruction, which can lead to serious complications like thrombosis. Therefore, close monitoring allows for early detection and intervention to prevent adverse outcomes. Option A is correct because it addresses a specific and common complication associated with heparin therapy, highlighting the importance of regular platelet monitoring to ensure patient safety. Options B, C, and D are incorrect because they do not directly relate to the monitoring requirements of heparin therapy. Monitoring electrolytes for elevated potassium levels, INR levels, or blood pressure is not typically associated with heparin therapy specifically. In an educational context, understanding the rationale behind monitoring requirements in heparin therapy is essential for healthcare professionals to provide safe and effective care to patients. By emphasizing the significance of regular platelet monitoring, this question reinforces the need for vigilant monitoring practices in hematology to prevent and manage potential complications.

Question 2 of 5

A patient is having hip replacement surgery and would like to self-donate blood for the surgery. In addition to being prescribed epogen alfa he should also be prescribed:

Correct Answer: B

Rationale: In this scenario, the correct answer is option B) Iron, to start when the epogen starts. Explanation: - Iron is essential for the production of red blood cells, which are necessary for oxygen transport in the body. Epogen alfa (a form of erythropoietin) stimulates the bone marrow to produce more red blood cells, and adequate iron levels are crucial for this process to be effective. - Without sufficient iron, the patient may develop iron-deficiency anemia, which could compromise the success of the self-donation and ultimately impact the patient's ability to recover well from the surgery. Why other options are wrong: - Option A) Folic acid is important for red blood cell production, but in this case, iron is more critical as it directly supports the action of epogen alfa. - Option C) An antihypertensive medication is unrelated to the patient's need for self-donation and does not address the specific requirements for the hip replacement surgery. - Option D) Vitamin B12 is not directly relevant in this context as the primary concern is ensuring adequate iron levels for erythropoiesis. Educational context: Understanding the interactions between different hematologic drugs and their respective roles in supporting red blood cell production is crucial for healthcare professionals managing patients undergoing surgeries, especially those involving blood loss. Ensuring appropriate supplementation, like iron in this case, is essential to optimize patient outcomes and prevent complications like anemia.

Question 3 of 5

Patients with pernicious anemia require treatment with:

Correct Answer: D

Rationale: In the treatment of pernicious anemia, patients require Vitamin B12 supplementation. Pernicious anemia is primarily caused by a deficiency in intrinsic factor, a substance needed for the absorption of Vitamin B12 in the small intestine. Therefore, providing Vitamin B12 is essential to bypass the need for intrinsic factor in these patients. Iron (Option A) is not the correct choice for pernicious anemia as it is used to treat iron-deficiency anemia, which is a different condition caused by low iron levels in the body. Folic acid (Option B) is used in the treatment of megaloblastic anemias, but it does not address the underlying Vitamin B12 deficiency seen in pernicious anemia. Epogen alfa (Option C) is a medication that stimulates red blood cell production and is used in conditions like chronic kidney disease-induced anemia, not pernicious anemia. In an educational context, understanding the specific treatment requirements for different types of anemia is crucial for healthcare professionals to provide appropriate care to patients. Knowing the rationale behind each treatment option helps in making informed clinical decisions and delivering optimal patient outcomes. By grasping the nuances of each condition and its corresponding treatments, healthcare providers can ensure effective and targeted interventions for their patients.

Question 4 of 5

A patient taking carbamazepine needs to be started on a direct factor Xa inhibitor for antithrombotic therapy. Which of the direct factor Xa inhibitors should be avoided due to drug interactions?

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Rivaroxaban. When a patient is taking carbamazepine, it induces the metabolism of many drugs via the cytochrome P450 enzyme system. Rivaroxaban is metabolized by both CYP3A4 and CYP2J2 enzymes, and carbamazepine is a potent inducer of CYP3A4. This interaction can significantly reduce the plasma levels of rivaroxaban, leading to decreased efficacy of the antithrombotic therapy. Option A) Betrixaban, Option B) Apixaban, and Option D) Edoxaban are not primarily metabolized by CYP3A4 and are not significantly affected by carbamazepine-induced enzyme activity. Therefore, they would be more suitable choices for antithrombotic therapy in a patient taking carbamazepine. Educationally, understanding drug interactions is crucial for healthcare providers to ensure safe and effective treatment for patients. Knowledge of how certain drugs affect the metabolism of others can help in making informed decisions when selecting medications, preventing potential adverse effects or treatment failures. It highlights the importance of individualizing therapy based on a patient's specific clinical profile and medication regimen.

Question 5 of 5

A patient who is suspected of having acute viral hemorrhagic fever reveals history of tick bite. Which of the following is the most possible causative agent?

Correct Answer: C

Rationale: In this scenario, the most probable causative agent of acute viral hemorrhagic fever following a tick bite is Crimean Congo virus (Option C). This is because Crimean Congo virus is a tick-borne virus belonging to the Nairovirus genus of the Bunyaviridae family. Educational Context: Understanding the etiology of viral hemorrhagic fevers is crucial in the study of hematology drugs as it impacts the management and treatment strategies for these conditions. By knowing the specific causative agents, healthcare professionals can tailor their approach to patient care, including the administration of appropriate medications and preventive measures. Explanation of Other Options: - A) Hantavirus: Hantavirus is primarily transmitted through rodent exposure, not tick bites. - B) Rift Valley virus: Rift Valley virus is transmitted by mosquitoes, not ticks. - D) Marburg virus: Marburg virus is transmitted through direct contact with infected individuals or animals, not tick bites. By understanding the specific modes of transmission of different viral agents, healthcare providers can accurately diagnose and treat patients, ultimately improving outcomes and reducing the spread of infectious diseases.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions